Immunocore Holdings plc (FRA:6YG)

Immunocore Holdings Revenue

Immunocore Holdings had revenue of $314.85M USD in the twelve months ending June 30, 2026, down -11.60% year-over-year. In the year 2025, Immunocore Holdings had annual revenue of $400.02M with 28.95% growth.

• Revenue (ttm): $314.85M
• Revenue Growth: -11.60%
• P/S Ratio: 3.78
• Revenue / Employee: $600.85K
• Employees: 524
• Market Cap: 1.42B EUR

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue by Geography

Chart

• United States 257.00M 64.2%
• Europe 131.42M 32.9%
• International 11.60M 2.9%

Fiscal year ended Dec 31, 2025 See the full Immunocore Holdings breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	400.02M	89.81M	28.95%
Dec 31, 2024	310.20M	60.77M	24.37%
Dec 31, 2023	249.43M	75.53M	43.44%
Dec 31, 2022	173.89M	138.04M	384.99%
Dec 31, 2021	35.85M	-5.32M	-12.91%
Dec 31, 2020	41.17M	7.13M	20.95%
Dec 31, 2019	34.04M	3.91M	12.98%
Dec 31, 2018	30.13M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error